Skip to main content

Advertisement

SpringerLink
Log in

Effects of hormone replacement therapy on the sympathetic nervous system and blood pressure

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension is a major health problem that significantly contributes to heart disease and stroke. While most studies of hypertension have focused on men, women also experience significant hypertension-related morbidity and mortality. However, the incidence of hypertension and cardiovascular disease is significantly lower in premenopausal women compared with men until the onset of menopause, at which time cardiovascular disease incidence increases dramatically in women and eventually approaches that in men. These observations indicate that the loss of estrogen contributes to menopause-related increases in blood pressure and cardiovascular disease, and suggest that the use of estrogen hormone replacement therapy could decrease the incidence of cardiovascular disease in postmenopausal women. However, new findings from the Women’s Health Initiative study suggest that estrogen therapy has few positive benefits and some significant negative effects on the health of postmenopausal women, and these data have caused many to abandon long-term estrogen replacement therapy. Conversely, numerous clinical and basic research studies indicate that estrogen replacement therapy beneficially reduces blood pressure, thereby decreasing the incidence of hypertension and cardiovascular disease. Further, several of these studies suggest that one means by which estrogen lowers blood pressure is by decreasing sympathetic nervous system activity. This review examines the evidence supporting estrogen’s ability to modulate sympathetic nervous system tone and thereby decrease arterial pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Pickering SG: Hypertension: definitions, natural histories, and consequences. In Hypertension: Pathophysiology, Diagnosis and Management, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:3–16.

    Google Scholar 

  2. Cohen E, Wheat ME, Swiderski DM, Charney P: Hypertension in women. In Hypertension: Pathophysiology, Diagnosis, and Management, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:159–169.

    Google Scholar 

  3. Ledingham JM: The vascular fault in hypertension: Byrom’s work revisited. In Hypertension: Pathophysiology, Diagnosis, and Management, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:37–53.

    Google Scholar 

  4. Kotchen JM, McKean HE, Kotchen TA: Blood pressure trends with aging. Hypertension 1982, 4:128–134.

    Google Scholar 

  5. Kannel WB: Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 1995, 18:181–196.

    PubMed  CAS  Google Scholar 

  6. Ross RK, Paganini-Hill A, Mack TM, et al.: Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981, 858–860.

  7. Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002, 288:321–333. This study demonstrated that hormone replacement therapy lacked significant cardiovascular benefits and was associated with slight increases in cardiovascular disease, thereby becoming the impetus for questioning hormone replacement therapy. Questions still remain as to the generalizability of the findings.

    Article  PubMed  CAS  Google Scholar 

  8. Gorodeski GI: Update on cardiovascular disease in postmenopausal women. Best Pract Res Clin Obstet Gynaecol 2002, 16:329–355.

    Article  PubMed  Google Scholar 

  9. Harvey PJ, Wing LM, Savage J, Molloy D: The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women. J Hypertens 1999, 17:405–411. Estrogen replacement therapy decreased nighttime arterial pressure ("dipping") in postmenopausal women. Nondipping, in which nighttime blood pressure fails to decline, has been linked as a precursor to the development of hypertension.

    Article  PubMed  CAS  Google Scholar 

  10. Vongpatanasin W, Tuncel M, Mansour Y, et al.: Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001, 103:2903–2908. This paper demonstrates that when delivered by a transdermal route, estrogen reduces blood pressure and sympathetic nerve activity.

    PubMed  CAS  Google Scholar 

  11. Myers J, Morgan T: The effect of sodium intake on the blood pressure related to age and sex. Clin Exp Hypertens Theory Pract 1983, 5:118.

    Google Scholar 

  12. Nestel PJ, Clifton PM, Noakes M, et al.: Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist: hip ratio. Hypertension 1993, 11:1387–1194.

    Article  CAS  Google Scholar 

  13. Murakami K, Kojim S, Kimur G, et al.: The association between salt sensitivity of blood pressure and family history of hypertension. Clin Exp Pharmacol Physiol 1992, 20:61–63.

    CAS  Google Scholar 

  14. Tominaga T, Suzuki H, Ogata Y, et al.: The role of sex hormones and sodium intake in postmenopausal hypertension. J Hum Hypertens 1991, 5:495–500.

    PubMed  CAS  Google Scholar 

  15. Kuiper GG, Carlsson B, Grandien K, et al.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863–870.

    Article  PubMed  CAS  Google Scholar 

  16. Zoubina EV, Smith PG: Distributions of estrogen receptors alpha and beta in sympathetic neurons of female rats: enriched expression by uterine innervation. J Neurobiol 2002, 52:14–23.

    Article  PubMed  CAS  Google Scholar 

  17. Zoubina EV, Smith PG: Sympathetic hyperinnervation of the uterus in the estrogen receptor alpha knock-out mouse. Neuroscience 2001, 103:237–244.

    Article  PubMed  CAS  Google Scholar 

  18. Dubal DB, Zhu H, Yu J, et al.: Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 2001, 98:1952–1957.

    Article  PubMed  CAS  Google Scholar 

  19. Blurton-Jones M, Tuszynski MH: Estrogen receptor-beta colocalizes extensively with parvalbumin-labeled inhibitory neurons in the cortex, amygdala, basal forebrain, and hippocampal formation of intact and ovariectomized adult rats. J Comp Neurol 2002, 452:276–287. Interestingly, ERβ receptors tend to localize to inhibitory neurons in the cardiovascular control nuclei in the brain. This suggests a role in inhibitory transmission.

    Article  PubMed  Google Scholar 

  20. Isgor C, Huang GC, Akil H, Watson SJ: Correlation of estrogen beta-receptor messenger RNA with endogenous levels of plasma estradiol and progesterone in the female rat hypothalamus, the bed nucleus of stria terminalis and the medial amygdala. Brain Res Mol Brain Res 2002, 106:30.

    Article  PubMed  CAS  Google Scholar 

  21. Green PS, Gridley KE, Simpkins JW: Nuclear estrogen receptorindependent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 1998, 84:7–10.

    Article  PubMed  CAS  Google Scholar 

  22. Weitz G, Elam M, Born J, et al.: Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J Clin Endocrinol Metab 2001, 86:344–348. Using similar techniques to those of Vongpatanasin et al. [10••], this paper found estrogen therapy reduced nerve traffic but not blood pressure, indicating that the change in blood pressure in estrogentreated women may not be caused by a reduction in nerve traffic.

    Article  PubMed  CAS  Google Scholar 

  23. Sahiner T, Aktan E, Kaleli B, Oguzhanoglu A: The effects of postmenopausal hormone replacement therapy on sympathetic skin response. Maturitas 1998, 30:85–88.

    Article  PubMed  CAS  Google Scholar 

  24. Sudhir K, Elser MD, Jennings GL, Komesaroff PA: Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997, 30:1538–1543.

    PubMed  CAS  Google Scholar 

  25. Mercuro G, Podda A, Pitzalis L, et al.: Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am J Cardiol 2000, 85:787–789. This study demonstrated a decrease in baroreflex inhibition of heart rate and sympathetic overactivity in oophorectomized women.

    Article  PubMed  CAS  Google Scholar 

  26. Saleh MC, Connell BJ, Saleh TM: Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 2000, 879:105–114. Using direct microinjection of estrogen into central nuclei associated with sympathetic nervous system regulation, the authors demonstrate a central role for estrogen as well as possible alterations in central estrogen receptor distribution in estrogen-depleted rats.

    Article  PubMed  CAS  Google Scholar 

  27. Saleh TM, Connell BJ: 17beta-estradiol modulates baroreflex sensitivity and autonomic tone of female rats. J Autonom Nerv Sys 2000, 80:148–161.

    Article  CAS  Google Scholar 

  28. Blum I, Vered Y, Lifshitz A, et al.: The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 1996, 32:1158–1162.

    PubMed  CAS  Google Scholar 

  29. Yildirir A, Kabakci G, Akgul E, et al.: Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Ann Noninvas Electrocardiol 2002, 7:60–63.

    Article  Google Scholar 

  30. Lewandowski J, Pruszczyk P, Elaffi M, et al.: Blood pressure, plasma NPY and catecholamines during physical exercise in relation to menstrual cycle, ovariectomy, and estrogen replacement. Regul Pept 1998, 76:239–245.

    Article  Google Scholar 

  31. Villecco AS, de Aloysio D, Radi D, et al.: Plasma catecholamines in pre- and in postmenopausal women with mild to moderate essential hypertension. J Hum Hypertens 1997, 11:157–162.

    Article  PubMed  CAS  Google Scholar 

  32. Menozzi R, Cagnacci A, Zanni AL, et al.: Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol. Maturitas 2000, 34:275–281.

    Article  PubMed  CAS  Google Scholar 

  33. Burleson MH, Malarkey WB, Cacioppo JT, et al.: Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med 1998, 60:17–25.

    PubMed  CAS  Google Scholar 

  34. Bairey Merz CN, Kop W, Krantz DS, et al.: Cardiovascular stress response and coronary artery disease: evidence of an adverse postmenopausal effect in women. Am Heart J 1998, 135:881–887.

    Article  PubMed  CAS  Google Scholar 

  35. Del Rio G, Velardo A, Zizzo G, et al.: Effect of estradiol on the sympathoadrenal response to mental stress in normal men. J Clin Endocrinol Metab 1994, 79:836–840.

    Article  PubMed  Google Scholar 

  36. Virtanen I, Polo O, Polo-Kantola P, et al.: The effect of estrogen replacement therapy on cardiac autonomic regulation. Maturitas 2000, 37:45–51.

    Article  PubMed  CAS  Google Scholar 

  37. Saleh MC, Connell BJ, Saleh TM: Medullary and intrathecal injections of 17beta-estradiol in male rats. Brain Res 2000, 867:200–209.

    Article  PubMed  CAS  Google Scholar 

  38. De Meersman RE, Zion AS, Giardina EG, et al.: Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women. Am J Physiol 1998, 274:H1539-H1544.

    PubMed  Google Scholar 

  39. Hunt BE, Taylor JA, Hamner JW, et al.: Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women. Circulation 2001, 103:2909–2914. The authors demonstrate that estrogen replacement therapy can directly alter baroreflex control of sympathetic activity in humans.

    PubMed  CAS  Google Scholar 

  40. el Mas MM, Abdel-Rahman AA: Estrogen enhances baroreflex control of heart rate in conscious ovariectomized rats. Can J Physiol Pharmacol 1998, 76:381–386.

    Article  PubMed  Google Scholar 

  41. Saleh TM, Connell BJ: Role of 17beta-estradiol in the modulation of baroreflex sensitivity in male rats. Am J Physiol Regul Integr Comp Physiol 1998, 275:R770-R778.

    CAS  Google Scholar 

  42. Saleh TM, Connell BJ: Centrally mediated effect of 17betaestradiol on parasympathetic tone in male rats. Am J Physiol Regul Integr Comp Physiol 1999, 276:R474-R481.

    CAS  Google Scholar 

  43. Saleh TM, Connell BJ, Saleh MC: Acute injection of 17betaestrodiol enhances cardiovascular reflexes and autonomic tone in ovariectomized female rats. Auton Neurosci 2000, 84:78–88.

    Article  PubMed  CAS  Google Scholar 

  44. He XR, Wang W, Crofton JT, Share L: Effects of 17beta-estradiol on the baroreflex control of sympathetic activity in conscious ovariectomized rats. Am J Physiol 1999, 277:R493-R498.

    PubMed  CAS  Google Scholar 

  45. Osborn JW, Provo BJ: Salt-dependent hypertension in the sinoaortic denervated rat. Hypertension 1992, 19:658–662.

    PubMed  CAS  Google Scholar 

  46. Krizsan-Agbas D, Smith PG: Estrogen modulates myometriuminduced sympathetic neurite formation through actions on target and ganglion. Neuroscience 2002, 114:339–347. Estrogen is shown to directly affect nerve growth and survival.

    Article  PubMed  CAS  Google Scholar 

  47. Zoubina EV, Mize AL, Alper RH, Smith PG: Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats. Histol Histopathol 2001, 16:989–996.

    PubMed  CAS  Google Scholar 

  48. De Meersman RE, Zion AS, Giardina EGáV, et al.: Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women. Am J Physiol Heart Circ Physiol 1998, 274:H1539-H1544.

    Google Scholar 

  49. Dodt C, Fehm HL, Weitz G: Effect of estrogen replacement therapy on sympathetic activity in postmenopausal women. Circulation 2001, 104:E161-E162.

    PubMed  CAS  Google Scholar 

  50. Fang Z, Carlson SH, Chen YF, et al.: Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1934-R1939. This paper demonstrates that although estrogen depletion has only a negligible effect on arterial pressure in spontaneously hypertensive rat females on a basal diet, a high-NaCl diet raises arterial pressure nearly three times as much in estrogen-depleted compared with intact spontaneously hypertensive rats. This suggests that the role of estrogen in arterial pressure control may be modified by several environmental factors, including diet.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Biology, University of Alabama at Birmingham, 35294-0006, Birmingham, AL, USA

    J. Michael Wyss PhD

Authors
  1. J. Michael Wyss PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott H. Carlson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wyss, J.M., Carlson, S.H. Effects of hormone replacement therapy on the sympathetic nervous system and blood pressure. Current Science Inc 5, 241–246 (2003). https://doi.org/10.1007/s11906-003-0027-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-003-0027-8

Keywords

Search

Navigation